Treatment of Bing–Neel syndrome with first line sequential chemoimmunotherapy
Article 2019 en
Authors
MG
Maria Gavriatopoulou
IN
Ioannis Ntanasis‐Stathopoulos
LM
Lia A. Moulopoulos
Abstract
1 min read
We propose a novel sequential chemoimmunotherapy approach for BNS treatment aiming both at rapid disease control and deep and durable remission with minimization of induced toxicity.
Monique C. Minnema, Eva Kimby, Shirley D’Sa, Luc‐Matthieu Fornecker, Stéphanie Poulain, Tom J. Snijders, Efstathios Kastritis, Stéphane Kremer, Aikaterini Fitsiori, Laurence Simon, Frédéric Davi, Michael P. Lunn, Jorge J. Castillo, Christopher J. Patterson, Magali Le Garff‐Tavernier, Myrto Costopoulos, Véronique Leblond, Marie José Kersten, Meletios A Dimopoulos, Steven P. Treon
Elena Shklovskaya, Jenny Lee, Su Yin Lim, Ashleigh Stewart, Bernadette Pedersen, Peter M. Ferguson, Robyn P.M. Saw, John F. Thompson, Brindha Shivalingam, Matteo S. Carlino, Richard A Scolyer, Alexander M. Menzies, Georgina V. Long, Richard Kefford, Helen Rizos
Véronique Leblond, Efstathios Kastritis, Ranjana H. Advani, Stephen M. Ansell, Christian Buske, Jorge J. Castillo, Ramón García‐Sánz, Morie A. Gertz, Eva Kimby, Charalampia Kyriakou, Giampaolo Merlini, Monique C. Minnema, Pierre Morel, Enrica Morra, Mathias Rummel, Ashutosh Wechalekar, Christopher J. Patterson, Steven P. Treon, Meletios A Dimopoulos
Meletios A Dimopoulos, Efstathios Kastritis, Roger G. Owen, Robert A. Kyle, Ola Landgren, Enrica Morra, Xavier Leleu, Ramón García‐Sánz, Nikhil C. Munshi, Kenneth C. Anderson, Evangelos Terpos, Irene M. Ghobrial, Pierre Morel, David G. Maloney, Mathias Rummel, Véronique Leblond, Ranjana H. Advani, Morie A. Gertz, Charalampia Kyriakou, Sheeba K. Thomas, Bart Barlogie, Stephanie A. Gregory, Eva Kimby,
Discussion(0)
No comments yet. Be the first to comment.